Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention-Reference-Cited by-同舟云学术

Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention

Published:2018-11-27 Issue:2 Volume:13 Page:157-171
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Di Ciaula Agostino¹^ORCID,Wang David Q-H²,Portincasa Piero³^ORCID

Affiliation:

1. Division of Internal Medicine, Hospital of Bisceglie, Bisceglie, Italy

2. Department of Medicine, Division of Gastroenterology and Liver Diseases, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY, USA

3. Department of Biomedical Sciences and Human Oncology, Clinica Medica “A. Murri”, University of Bari Medical School, Bari, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2019.1549988

Reference330 articles.

1. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe

2. Cholesterol gallstone disease

3. Incidence of gallstone disease and complications

4. Epidemiology of Gallstone Disease in Italy: Prevalence Data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)

5. Factors associated with gallstone disease in the MICOL experience

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and gallstones among US adults aged ≤ 50 years: a cross-sectional study from NHANES 2017–2020;Lipids in Health and Disease;2024-08-22

2. Predictive value of bile acids as metabolite biomarkers for gallstone disease: A systematic review and meta-analysis;PLOS ONE;2024-07-25

3. Cholesterol Gallstones and Long-Term Use of Statins: Is Gut Microbiota Dysbiosis Bridging over Uncertainties?;Diagnostics;2024-06-12

4. Higher levels of systemic immune-inflammatory index are associated with the prevalence of gallstones in people under 50 years of age in the United States: a cross-sectional analysis based on NHANES;Frontiers in Medicine;2024-01-12

5. Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico;Revista de Gastroenterología de México (English Edition);2023-07